Eric Linsley
Fondateur chez BioLabs, Inc. (California)
Profil
Eric W.
Linsley is the founder of BioLabs, Inc. (California) founded in 2016.
He currently holds director positions at Cequent Pharmaceuticals, Inc., Cereius, Inc., and is a General Partner at BioInnovation Management LLC since 2017.
He is also the Chief Financial Officer at Envisia Therapeutics, Inc. since 2015.
Mr. Linsley has held director positions at various companies including V.I.
Technologies, Inc., BioSyntech, Inc., Sensys Medical Ltd., BaroSense, Inc., Milestone Pharmaceuticals, Inc., Emerald BioAgriculture Corp., FlowCardia, Inc., Panacos Pharmaceuticals, Inc., and Gentis, Inc. He was also the Chief Financial Officer at TriPath Imaging, Inc. from 1997 to 2000 and the Partner at Ampersand Management LLC from 1994 to 1997.
Mr. Linsley was a Partner at Pappas Capital LLC from 2000 to 2011 and the Chief Financial Officer & VP-Operations at AutoCyte, Inc. He received his undergraduate degree from Trinity University, his MBA from the University of Pennsylvania, and his graduate degree from New York University.
Postes actifs de Eric Linsley
| Sociétés | Poste | Début |
|---|---|---|
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Directeur Financier/CFO | 18/06/2015 |
Cereius, Inc.
 Cereius, Inc. BiotechnologyHealth Technology Cereius, Inc. develops novel radio-labeled therapeutics for treating solid tumor brain metastasis. The firm delivers new targeted classes of both radiologic diagnostics and radiotherapeutics for the treatment of cancers in the brain. The company was founded by Kimberly Blackwell and Michael R. Zalutsky in 2017 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
BioInnovation Management LLC
 BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/01/2017 |
BioLabs, Inc. (California)
 BioLabs, Inc. (California) Medical/Nursing ServicesHealth Services BioLabs, Inc. provides clinical laboratory services. It offers clinical and anatomical laboratory services to physician offices, clinics, subacute treatment centers, public sector entities and home-bound patients. The company was founded in June 2006 and is headquartered in Santa Ana, CA. | Fondateur | 01/01/2016 |
Anciens postes connus de Eric Linsley
| Sociétés | Poste | Fin |
|---|---|---|
Sensys Medical Ltd.
 Sensys Medical Ltd. Medical DistributorsDistribution Services Since 1995, Sensys Medical, Inc. (f.k.a. Instrumentation Metrics) has been diligently working on the development of a non-invasive blood glucose analyzer to assist those individuals with diabetes control their blood sugar levels. The Company intends to commercialize its Glucose Tracking System (GTSâ'¢), which will dramatically advance the practice of blood glucose monitoring and the science of diabetes disease management. Sensys Medical continues to advance the technologies necessary to successfully develop a device that is accurate, precise and simple to use in the hands of individuals. Sensys Medical scientists and engineers have furthered the understanding of non-invasive blood glucose measurement with advancements in the disciplines of tissue optics, multivariate statistics, optical engineering and analysis, detector materials, finite element analysis and applied computational fluid dynamics. These advances are continually tested in clinical trials and refined to ensure that individuals are capable of obtaining accurate non-invasive blood glucose measurements with minimal effort from the subject. As results from these trials become available, they will be shared through presentations and/or publications. | Directeur/Membre du Conseil | 03/03/2011 |
| PANACOS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/04/2007 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Directeur/Membre du Conseil | 19/08/2005 |
TriPath Imaging, Inc.
 TriPath Imaging, Inc. Pharmaceuticals: MajorHealth Technology TriPath Imaging, Inc. engages in the development, manufacture, and market of equipment and products for cervical cytology screening. The company was founded on November 15, 1996 and is headquartered in Burlington, NC. | Directeur Financier/CFO | 01/01/2000 |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Linsley
| Trinity University | Undergraduate Degree |
| University of Pennsylvania | Masters Business Admin |
| New York University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOSYNTECH, INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
TriPath Imaging, Inc.
TriPath Imaging, Inc. Pharmaceuticals: MajorHealth Technology TriPath Imaging, Inc. engages in the development, manufacture, and market of equipment and products for cervical cytology screening. The company was founded on November 15, 1996 and is headquartered in Burlington, NC. | Health Technology |
Sensys Medical Ltd.
Sensys Medical Ltd. Medical DistributorsDistribution Services Since 1995, Sensys Medical, Inc. (f.k.a. Instrumentation Metrics) has been diligently working on the development of a non-invasive blood glucose analyzer to assist those individuals with diabetes control their blood sugar levels. The Company intends to commercialize its Glucose Tracking System (GTSâ'¢), which will dramatically advance the practice of blood glucose monitoring and the science of diabetes disease management. Sensys Medical continues to advance the technologies necessary to successfully develop a device that is accurate, precise and simple to use in the hands of individuals. Sensys Medical scientists and engineers have furthered the understanding of non-invasive blood glucose measurement with advancements in the disciplines of tissue optics, multivariate statistics, optical engineering and analysis, detector materials, finite element analysis and applied computational fluid dynamics. These advances are continually tested in clinical trials and refined to ensure that individuals are capable of obtaining accurate non-invasive blood glucose measurements with minimal effort from the subject. As results from these trials become available, they will be shared through presentations and/or publications. | Distribution Services |
BaroSense, Inc.
 BaroSense, Inc. Medical SpecialtiesHealth Technology BaroSense Inc. operates as a medical device company that focuses on the research and development of minimally invasive medical devices for the treatment of obesity. The company was founded by Richard S. Stack and William N. Starling, Jr. in 2001 and is headquartered in Redwood City, CA. | Health Technology |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
Emerald BioAgriculture Corp.
 Emerald BioAgriculture Corp. Agricultural Commodities/MillingProcess Industries Emerald BioAgriculture Corp. develops, manufactures, and markets crop protection products. The firm provides applications from modern biology to crop yields that combat disease and fight pests. It also provides agricultural products and consultant services. The company was founded in 1994 and is headquartered in Okemos, MI. | Process Industries |
AutoCyte, Inc.
 AutoCyte, Inc. Medical SpecialtiesHealth Technology AutoCyte Inc develops, manufactures and markets the only integrated automated sample preparation and image analysis system to support cytotechnologists and pathologists in cervical caner screening. | Health Technology |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
BioLabs, Inc. (California)
BioLabs, Inc. (California) Medical/Nursing ServicesHealth Services BioLabs, Inc. provides clinical laboratory services. It offers clinical and anatomical laboratory services to physician offices, clinics, subacute treatment centers, public sector entities and home-bound patients. The company was founded in June 2006 and is headquartered in Santa Ana, CA. | Health Services |
Gentis, Inc.
 Gentis, Inc. Medical SpecialtiesHealth Technology Gentis, Inc. engages in the development and testing technologies for the minimally invasive treatments. The company was founded by Charles Cohen and Paul Ducheyne in 2000 and is headquartered in Wayne, PA. | Health Technology |
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Health Technology |
Cereius, Inc.
Cereius, Inc. BiotechnologyHealth Technology Cereius, Inc. develops novel radio-labeled therapeutics for treating solid tumor brain metastasis. The firm delivers new targeted classes of both radiologic diagnostics and radiotherapeutics for the treatment of cancers in the brain. The company was founded by Kimberly Blackwell and Michael R. Zalutsky in 2017 and is headquartered in Durham, NC. | Health Technology |
